#Asceneuron_SA is delighted to announce the appointment of Barbara Angehrn Pavik as the new Chief Executive Officer (CEO), as part of a leadership transition poised to propel the company into its next phase of growth, with two compounds in clinical development. Dirk Beher, co-founder of Asceneuron, its original Chief Scientific Officer, and CEO since 2014, will transition to the key role of Chief Scientific Advisor. 👉 https://lnkd.in/ezzmFNAp
Welcome on board to Asceneuron, Barbara!
Scientific Expert and Adviser in Drug Discovery & Development - Former Head of CNS Med Chem Sanofi, former President of the French medicinal chemistry Society
11moNice to see the company is moving ahead. Perhaps reconnect with you after a long time when I was making the DD of the projects 🤗